ARTES Biotechnology announce expansion of the management board
ARTES Biotechnology GmbH announced today that Volker Jenzelewski reinforces the executive board of ARTES as Managing Dir…
ARTES Biotechnology GmbH announced today that Volker Jenzelewski reinforces the executive board of ARTES as Managing Dir…
Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today the deta…
Billions of injections are administered worldwide on an annual basis. Nonetheless, the conventional approach via hypoder…
After receiving priority review in 2018, CIMZIA® (certolizumab pegol) is now approved in China for the treatment of Mode…
AMSBIO has added new experimental cell lines to its CAR T cell research range. Recent FDA approval of CAR T cells for…
Immatics, a leading company in the field of cancer immunotherapy, today announced that the United States Patent and Trad…
ARTES Biotechnology announces the acquisition of the unique SplitCore technology developed by scientists at the Universi…
Under the titel: “ERA-Net EuroTransBio-8: PLURIVAX, development of a virus-like-particle (VLP) based vaccine platform an…
ARTES Biotechnology specialized in microbial process development and technology transfer for pharmaceutical industry is…
Ad19a, the latest in adenoviral (AV) gene vector innovations, has generated first data in preclinical vaccination tests…